Established in 1996, SNELL offers an extensive range and depth of experience in strategic support and specialized communications services to a broad spectrum of healthcare stakeholders. Through our offices in Montreal and New York, SNELL conducts business
for and on behalf of biopharmaceutical and health technology companies in North America, Latin America, Europe and Asia.
Our integrated areas of expertise, including clinical science, health economics and outcomes research, medical education and
medical publishing, offer clients seamless communication synergies throughout the drug development, approval, reimbursement,
and commercialization continuum.
Separately and independently, SNELL supports medical faculties and societies in creating and executing peer-to-peer educational programs and events that provide authoritative evidence-based reviews and perspective on evolving and emerging science and, most importantly, the relevance to clinical practice.
Central to SNELL’s strength and success are our teams of accomplished scientific, communications and project management specialists. Their multi-disciplined skills converge to create innovative evidence-based programs and events that are scientifically accurate, highly engaging and verifiably effective. SNELL enjoys enduring working relationships with an expansive network of national
and international physician experts and academicians who help guide our teams in the development and execution of a diverse
range of projects.